Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt

Clinical Nephrology

Volumn 50, Issue 2, 1998, Pages 118-122

  Azoulay, D ^a,c,e   Castaing, D ^a,e   Lemoine, A ^b,e   Samuel, D ^a,e   Majno, P ^a,e   Reynes, M ^c,e   Charpentier, B ^d,e   Bismuth, H ^a,e  

^a Centre Hépato Biliaire   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d BICÊTRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Azathioprine; Transjugular intrahepatic portosystemic shunt; Veno occlusive disease

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; DRUG WITHDRAWAL; EMERGENCY SURGERY; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; LIVER VEIN OBSTRUCTION; MALE; PORTOSYSTEMIC ANASTOMOSIS;

ADULT; AZATHIOPRINE; BIOPSY; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER; MALE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 0031659629     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Adler M, Delhaye M, Deprez C, Hardy N, Gelin M, De Pauw L, Vereerstraeten P, Cremer M, Toussaint C 1987 Hepatic vascular disease after kidney transplantation: Report of two cases and review of the literature. Nephrol Dial Transplant 2: 183-188
2. Azoulay D, Castaing D, Dennison A, Martino W, Bismuth H 1994 Technique and pitfalls of transjugular intrahepatic portosystemic shunt. In: Steichen FM, Welter R (eds). Minimally invasive surgery and new technology. Quality Medical Publishing. St Louis, pp 182-191
3. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H 1994 Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 19: 129-132
4. Bories P, Mourad G, Garnier T, Barneon G, Mion C, Michel H 1987 Péliose et hyperplasie régénérative du foie: une seule maladie en rapport avec l'azathioprine ou le cytomégalovirus? Gastroentérol Clin Biol 11: 72
5. Degott C, Rueff B, Kreis H, Duboust A, Potet F, Benhamou JP 1976 Peliosis hepatis in recipients of renal transplants. Gut 19: 748-753
6. DePinho RA, Goldberg CS, Lefkowitch JH 1984 Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepato-cellular injury in humans. Gastroenterology 86: 162-165
7. Dowlati A, Honore P, Damas P, Deprez M, Delwaid J, Fillet G, Beguin Y 1995 Hepatic rejection after orthopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation 60: 106-108
8. Eisenhaueur T, Hartman H, Rumpf KW, Helchen U, Scheler F, Creutzfeldt W 1984 Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portocaval shunt. Digestion 30: 185-190
9. Fried MW, Connaghan DG, Sharma S, Martin LG, Devine S, Holland K, Zuckerman A, Kaufman S, Wingard J, Boyer TD 1996 Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 24: 588-591
10. Haskal ZJ, Constantin C, Soulen MC, Shlanski-Goldberg RD, Baum RA, Redd DCB 1995 Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 195: 485-488
11. Hauenstein KH, Haag K, Ochs A, Langer M, Rössle M 1995 The reducing stent: Treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 194: 175-179
12. Jalan R, Hayes PC 1995 Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology 197: 587
13. Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD 1986 Azathioprine and hepatic veno-occlusive disease in renal transplant patients. Gastroenterology 90: 446-454
14. Lemley D, Delacy L, Seeff L, Ishak K, Nashel D 1989 Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis. Ann Rheum Dis 48: 342-346
15. Lévy V, Azoulay D, Rio B, Vincent F, Rabbat A, Hunault M, Bazarbachi A, Delmer A, Zittoun R 1996 Successful treatment of severe veno-occlusive disease after allogenic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS). Bone Marrow Transplant 18: 443-445
16. Liano F, Moreno A, Matesanz R, Teruel JL, Redondo C, Garcia-Martin F, Orte L, Ortuno J 1989 Veno-occlusive disease of the liver in renal transplantation: Is azathioprine the cause? Nephron 51: 509-516
17. Marubbio AT, Danielson B 1975 Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine. Gastroenterology 69: 739-743
18. Michielsen PP, Pelckmans PA, d'Archambeau OC, De Schepper AM, Van Marck EA, Meerman L, Haagsma EB, Jorens PG, Van Maercke YM 1995 Transjugular intrahepatic portosystemic shunt improves liver function in veno-occlusive disease. J Hepatol 21: 685-686
19. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW 1990 Successful treatment of hepatic veno-occlusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 49: 819-821
20. Norris S, Crosbie O, McEntee G, Traynor O, Nolan N, McCann S, Hegarty J 1997 Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation. Transplantation 63: 1521-1524
21. Ochs A, Sellinger M, Haag K, Nöldge G, Herbst EW, Walter E, Gerok W, Rössle 1993 Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18: 217-225
22. Paz-Fumagalli R, Crain MR, Mewissen MW, Varma RR 1994 Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 5: 831-834
23. Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF 1991 Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogenic bone marrow transplant. Bone Marrow Transplant 8: 421-424
24. Read AE, Wiesner RH, LaBrecque DR, Tifft JG, Mullen KD, Sheer RL, Petrelli M, Ricanati ES, McCullough AJ 1986 Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann Intern Med 104: 651-655
25. Smith FO, Johnson MS, Scherer LR, Faught P, Breitfeld PP, Albright E, Hillier SC, Gowan D, Smith PD, Robertson KA, Emanuel D 1996 Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease. Bone Marrow Transplant 18: 643-646
26. Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D 1989 Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9: 443-448
27. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, Lake J 1991 Azathioprine hepatotoxicity after liver transplantation. Hepatology 14: 806-810
28. Weitz H, Gopel JM, Loeschke K, Possinger K, Eder M 1982 Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch 395: 245-256
29. Zarday Z, Veith FJ, Gliedman ML, Soberman RS 1972 Irreversible liver damage after azathioprine. JAMA 222: 690-691